Carna Biosciences, Inc. (TYO:4572)
Japan flag Japan · Delayed Price · Currency is JPY
300.00
-6.00 (-1.96%)
Aug 1, 2025, 3:30 PM JST

Carna Biosciences Revenue

Carna Biosciences had revenue of 143.35M JPY in the quarter ending March 31, 2025, a decrease of -20.36%. This brings the company's revenue in the last twelve months to 598.71M, down -62.08% year-over-year. In the year 2024, Carna Biosciences had annual revenue of 636.00M, down -60.86%.

Revenue (ttm)
598.71M
Revenue Growth
-62.08%
P/S Ratio
9.97
Revenue / Employee
9.50M
Employees
63
Market Cap
5.97B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024636.00M-989.00M-60.86%
Dec 31, 20231.63B239.00M17.24%
Dec 31, 20221.39B-631.00M-31.28%
Dec 31, 20212.02B884.00M78.02%
Dec 31, 20201.13B-2.07B-64.67%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Chugai Pharmaceutical1,196.22B
Daiichi Sankyo Company1,886.26B
Takeda Pharmaceutical Company4,581.55B
HOYA Corporation866.03B
Otsuka Holdings2,393.18B
Terumo1,036.17B
Astellas Pharma1,912.32B
Shionogi &440.50B
Revenue Rankings